Lilly to seek U.S. approval for daily sleep apnea pill
The company plans to file for approval of a daily pill for adults with obesity suffering from moderate-to-severe obstructive sleep apnea by the end of the year.

Lilly plans to file for U.S. approval by the end of the year for a daily pill.
The medication is intended for adults with obesity who have moderate-to-severe obstructive sleep apnea.
Key facts
- Lilly plans to file for U.S. approval of a daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity by the end of the year.
Perspectives
Neutral
Lilly plans to file for U.S. approval of a daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity by the end of the year.
Positive
Lilly is seeking approval for a daily pill to treat moderate-to-severe obstructive sleep apnea in adults with obesity.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.
Next storyMayo Clinic study finds blood test may predict Alzheimer's risk years in advance